These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 20346231

  • 1. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
    Uchino A, Tsukamoto H, Nakashima H, Yoshizawa S, Furugo I, Mitoma H, Oryoji K, Shimoda T, Niiro H, Tada Y, Yano T, Nonaka T, Oishi R, Akashi K, Horiuchi T.
    Clin Exp Rheumatol; 2010; 28(1):6-12. PubMed ID: 20346231
    [Abstract] [Full Text] [Related]

  • 2. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
    Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E.
    Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719
    [Abstract] [Full Text] [Related]

  • 3. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E.
    Nephron Clin Pract; 2012 Dec; 121(3-4):c165-73. PubMed ID: 23327881
    [Abstract] [Full Text] [Related]

  • 4. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.
    Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E.
    Lupus; 2007 Dec; 16(11):896-900. PubMed ID: 17971363
    [Abstract] [Full Text] [Related]

  • 5. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.
    Tse KC, Lam MF, Tang SC, Tang CS, Chan TM.
    Lupus; 2007 Dec; 16(1):46-51. PubMed ID: 17283585
    [Abstract] [Full Text] [Related]

  • 6. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
    Fei Y, Wu Q, Zhang W, Chen H, Hou Y, Xu D, Li M, Zhang X, Zhao Y, Zeng X, Zhang F.
    Clin Exp Rheumatol; 2013 Dec; 31(1):62-8. PubMed ID: 22935463
    [Abstract] [Full Text] [Related]

  • 7. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study.
    Mok CC, Tong KH, To CH, Siu YP, Au TC.
    Kidney Int; 2005 Aug; 68(2):813-7. PubMed ID: 16014060
    [Abstract] [Full Text] [Related]

  • 8. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
    Mok CC, To CH, Yu KL, Ho LY.
    Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
    Tanaka H, Aizawa T, Watanabe S, Oki E, Tsuruga K, Imaizumi T.
    Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study.
    Miyasaka N, Kawai S, Hashimoto H.
    Mod Rheumatol; 2009 Jul; 19(6):606-15. PubMed ID: 19688181
    [Abstract] [Full Text] [Related]

  • 11. Long-term data on tacrolimus treatment in lupus nephritis.
    Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM.
    Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 13. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 14. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK.
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [Abstract] [Full Text] [Related]

  • 15. Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center.
    Karasawa K, Uchida K, Kodama M, Moriyama T, Nitta K.
    Rheumatol Int; 2018 Dec; 38(12):2271-2277. PubMed ID: 30203113
    [Abstract] [Full Text] [Related]

  • 16. Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center.
    Asamiya Y, Uchida K, Otsubo S, Takei T, Nitta K.
    Nephron Clin Pract; 2009 Dec; 113(4):c330-6. PubMed ID: 19729969
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis.
    Takahashi S, Hiromura K, Sakurai N, Matsumoto T, Ikeuchi H, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2011 Jun; 21(3):282-9. PubMed ID: 21188448
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.
    Nomura A, Shimizu H, Kishimoto M, Suyama Y, Rokutanda R, Ohara Y, Yamaguchi K, Okada M.
    Lupus; 2012 Nov; 21(13):1444-9. PubMed ID: 22917589
    [Abstract] [Full Text] [Related]

  • 19. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials.
    Lee YH, Lee HS, Choi SJ, Dai Ji J, Song GG.
    Lupus; 2011 May; 20(6):636-40. PubMed ID: 21382917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.